Navigation Links
Newly established neuroscience clinical trials center could bring treatments to patients faster
Date:12/1/2011

file.asp?id=4754&k=&O=1">Shlomo Shinnar, M.D., Ph.D., co-principal investigator on the grant. "Researchers and interested physicians with no research experience will be able to tap into an existing infrastructure that can provide the research and regulatory expertise to participate in these clinical trials. Normally, when you build a multi-center study, it can take a year or two to get the trial going. We hope to get this down to a few months." Dr. Shinnar is professor in the Saul R. Korey Department of Neurology and of pediatrics at Einstein and an attending physician at Montefiore.

Despite the difficulties in initiating these studies, significant advances have been made in recent years in the understanding and treatment of unusual neurological disorders.

"While common diseases like Alzheimer's and Parkinson's have been slow to give up their secrets, real progress has been made in discovering the origins of and therapies for rare neurological diseases," said Mark Mehler, M.D., professor and chair of the Saul R. Korey Department of Neurology at Einstein and chair of neurology at Montefiore. "While this initiative offers us an opportunity to dramatically change the lives of patients with these rare diseases, the findings are also likely to provide insight into more common neurological disorders, like migraine and stroke, which affect millions of people." Dr. Mehler also holds the Alpern Family Foundation Chair in Cerebral Palsy Research at Einstein.

The Einstein-NeuroNEXT includes over 150 adult neurologists and 25 pediatric neurologists who serve an unusually diverse population base of over 8 million. Einstein's clinical affiliates have neurological expertise across all age groups children, adults and geriatrics. Each year, these affiliates assess over 35,000 individual neurology patients, including more than 10,000 pediatric neurology patients. Eac
'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Newly identified gene mutation adds to melanoma risk
2. Newly Found Gene Mutations May Aid Heart Treatments
3. Two-thirds of newly diagnosed cancer patients unable to obtain oncology appointments
4. Newly discovered virus implicated in deadly Chinese outbreaks
5. Newly discovered role for enzyme in neurodegenerative diseases
6. Newly identified cell population key to immune response
7. More Sex May Help Neurotic Newlyweds
8. Drug combination shows promise for newly diagnosed blood cancer patients, study finds
9. Frequent sex protects marital happiness for neurotic newlyweds
10. Newly discovered regulatory mechanism essential for embryo development and may contribute to cancer
11. More Natural Fat Burning Foods & Ready-Made Meal Plans Added to the Newly Revised Version of The Diet Solution Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... 31, 2015 , ... Nine innovative healthcare companies (listed below) ... Healthcare(SM) Awards Event , on October 21, 2015, in Long Beach. The Event, ... and individuals who are dramatically reducing the cost of quality healthcare. , The ...
(Date:8/31/2015)... ... August 31, 2015 , ... Finnleo , a leader in the ... in the 3rd quarter, the newly re-styled and re-designed “Hallmark Series” updates the Passport ... These new models include more glass and a more upscale feel than the current ...
(Date:8/31/2015)... ... , ... The more hours young adults spend watching television each day, the ... circumference, a 15-year analysis by the University of Pittsburgh Graduate School of Public Health ... young adulthood is an important time to intervene and promote less television viewing, according ...
(Date:8/31/2015)... ... ... On Saturday, May 30th, 2015, Best Drug Rehabilitation sponsored a benefit concert known ... purpose behind this concert was to raise money for music education programs in the ... of “Music with a Mission” helped with a portion of the cost of holding ...
(Date:8/31/2015)... ... August 31, 2015 , ... "While working as an ... effectively deliver oxygen with a lower risk of failure," explained an inventor, from ... the Adam Device." , The Adam Device offers a quick, effective and predictable ...
Breaking Medicine News(10 mins):Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 2Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 4Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 5Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 6Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 7Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 8Health News:Finnleo Introduces Hallmark Series Saunas 2Health News:Watching More TV as a Young Adult Predicts Obesity 2Health News:Watching More TV as a Young Adult Predicts Obesity 3Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:InventHelp® Client's Invents Medical Device to Restore Respiratory Function (BGF-905) 2
... MONTREAL, June 11 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : ... ended April 30, and reports on its recently concluded ... Stategic Collaboration , , As previously announced on ... entered into a strategic collaboration which provides Angiotech with ...
... Continued Market Share Increase Combined with Significant Operating Efficiencies Lead to ... Cord Blood Registry (CBR), the global leader in ... blood, reported solid revenue growth in first quarter 2009, up nearly ... quarter showed even stronger gains due to increases in both volume ...
... ... for the quarter ending April 30, 2009. With consistent growth and increased orders, ... ... -- Clearly Contacts released their second quarter unaudited financial results today, for the ...
... ... savings for surgical instrument repairs. , ... Stow, OH (PRWEB) June 11, 2009 -- Spectrum Surgical Instruments is ... any model of surgical instrument and each repair is backed by our 100% Satisfaction ...
... U.S. House of Representatives voted 235-187 to approve H.R. ... new "Office for Global Women,s Issues" and directs that ... around the world. Secretary of State Hillary Clinton ... administration "will protect the rights of women, including their ...
... NORTH HOLLYWOOD, Calif., June 10 IPC The Hospitalist Company, Inc. ... company, announced today that management is scheduled to present at the ... in New York City. Adam Singer, M.D., Chairman and CEO, ... conference. IPC,s presentation will take place at 3:15 P.M. Eastern ...
Cached Medicine News:Health News:Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals, Inc. and Second Quarter 2009 Financial Results 2Health News:Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals, Inc. and Second Quarter 2009 Financial Results 3Health News:Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals, Inc. and Second Quarter 2009 Financial Results 4Health News:Cord Blood Registry Maintains Solid Growth in First Quarter 2009 2Health News:Cord Blood Registry Maintains Solid Growth in First Quarter 2009 3Health News:Clearly Contacts Announces Another Quarter Of Growth In The Economic Downturn 2Health News:Clearly Contacts Announces Another Quarter Of Growth In The Economic Downturn 3Health News:Three-Year Agreement for Surgical Instrument Repair Services 2Health News:IPC The Hospitalist Company, Inc. to Present at Jefferies 3rd Annual Healthcare Conference 2
(Date:8/31/2015)... Mich. , Aug. 31, 2015  Diplomat Pharmacy, Inc. ... has announced that Phil Hagerman , Chairman & CEO, ... upcoming investor conferences. Mr. Hagerman and Mr. ... Healthcare Conference in Boston on Wednesday, ... Hagerman and Mr. Whelan are also scheduled to participate in ...
(Date:8/31/2015)... , Aug. 31, 2015  AMRI (NASDAQ: ... announced a strategic collaboration focused on the development, ... active pharmaceutical ingredients, ("APIs"). The collaboration combines Saneca,s ... their expertise in developing and manufacturing controlled substance ... to tech transfer processes into these facilities. The ...
(Date:8/31/2015)... , Aug. 31, 2015 Bionomics Limited (ASX:BNO, ... development of innovative therapeutics for the treatment of diseases ... announced that its BNC101 IND submission has passed review ... plans to initiate a Phase 1 clinical trial in ... metastatic pancreatic cancer prior to 31 December 2015. ...
Breaking Medicine Technology:Diplomat to Participate in Upcoming Investor Conferences 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4
... Cancer Therapeutics CRC,Pty Ltd (CTx) has commenced ... its type in the world. Underpinned by ... million from the Australian Commonwealth Government, CTx addresses,the ... and its,ability to discovery and develop new drugs ...
... Pain Conditions; Compound ... -, LA JOLLA, Calif., Aug. 27 TorreyPines,Therapeutics, ... has initiated a,Phase I multiple dose clinical trial to ... a subcutaneous injection to,healthy male and female volunteers once-daily ...
Cached Medicine Technology:New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs 2New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs 3TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel 2TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel 3TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel 4
Inquire...
... Small Bone Power System combines precision ... under the most exacting conditions. The ... small bone osteotomies and oral/maxillofacial procedures ... Length Available), Oscillating Saw (Extended Length ...
... System is a specialized electric system ... designed for use in Otolaryngology, Neurosurgery, ... System consists of a specialized electric ... designed to provide precision and control ...
... The Brasseler USA™ Battery ... quickly and efficiently determine ... STR-2000, STR-3000 Extended Run, ... Driver™, Battery Packs contain ...
Medicine Products: